HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) represent a revolutionary technology in the field of genetic engineering and molecular biology. Originally discovered as a bacterial immune system, CRISPR has been repurposed as a powerful tool for precise genome editing in various organisms. The CRISPR system consists of two main components: guide RNA (gRNA) and the Cas9 protein. The gRNA guides the Cas9 protein to specific target sequences in the genome, where it induces double-strand breaks. These breaks can be repaired by the cell's own DNA repair machinery, leading to gene knockout, insertion, or modification. The simplicity, versatility, and efficiency of the CRISPR system have made it widely adopted in research laboratories worldwide. CRISPR technology has revolutionized gene editing, enabling researchers to edit genomes with unprecedented precision and ease. It has facilitated the study of gene function, disease modeling, and the development of novel therapies for genetic disorders. Additionally, CRISPR has applications beyond gene editing, including gene regulation, epigenome editing, and diagnostic tools. Despite its tremendous potential, CRISPR technology also raises ethical and societal concerns, particularly regarding off-target effects, germline editing, and the potential for unintended consequences. Ongoing research aims to address these challenges and refine the CRISPR system for safe and effective use in various applications.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a